참고문헌
- Blatter M-C, James RW, Messmer S, Barja F and Pornetta D. Identification of a distinct high-density lipoprotein subspecies defined by a lipoproteinassociated protein, K-45. Identity of K-45 with paraoxonase, Eur. J. Biochem. 1993; 211: 871-879 https://doi.org/10.1111/j.1432-1033.1993.tb17620.x
- Bostein D, White RL, Skolnick M and Davis RW. Construction of a genetic linkage map in man using restriction fragment length polymorphisms, Am. J. Hum. Genet. 1980; 3: 314-331
-
Bray MS, Krushkal J, Li L, Ferrell R, Kardia S, Sing CF, Tumer ST and Boerwinkle E.: Positional genomic analy-sis identifies the
$\beta$ 2-adrenergic receptor gene as a suscep-tibility locus for hypertension, Circulation 2000; 101: 2877-2882 https://doi.org/10.1161/01.CIR.101.25.2877 - Campo S, Sardo AM, Campo GM, Avenoso A, Castaldo M, D'Ascola A, Giunta E, Calatroni A and Saitta A. Identifi-cation of paraoxonase 3 gene (PON3) missense muta-tions in a population of southern Italy, Mutation Res 2004; 546: 75-80 https://doi.org/10.1016/j.mrfmmm.2003.11.007
- Choi TY, Lee YK, Kim WB, Lee DW, Hyon MS, Seo SW, Kim SK and Kwon YJ. A study on gene frequency of paraoxonase gene 2 in patients with coronary heart disease, Korean J. Clin. Pathol. 1999; 19: 420-424
-
Cusi D, Barlassina C, Azzani T, Casari G, Citterio L, Devoto M, Gloriso N, Lanzani C, Manunta P, Righetti M, Rivera R, Stella P, Troffa C, Zagato L and Bianchi G. Polymorphisms of
$\alpha$ -adducin and salt sensitivity in patients with essential hypertension, Lancet 1997; 349: 1353-1357 https://doi.org/10.1016/S0140-6736(97)01029-5 - Fridewald WT, Levy RI and Friedrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without the use of the preparative ultracen trifuge, Clin. Chem. 1972; 18: 499-502
- Furlong CE, Richter RJ, Seidel SJ and Motulsky A. Role of genetic polymorphism of human plasma paraoxonase/ arylesterase in hydrolysis of the insecticide metabolites chlorpyrifos oxon and paraoxon, Am. J. Hum. Genet. 1988; 43: 230-238
- Hong SH, Song J, Min WK and Kim JQ. Genetic variations of the paraoxonase gene in patients with coronary artery disease, Clin. Biochem. 2001; 34: 475-481 https://doi.org/10.1016/S0009-9120(01)00257-0
- Izawa H, Yamada Y, Okada T, Tanaka M, Hirayama H and Yokota M. Prediction of genetic risk for hypertension, Hypertension 2003; 41: 1035-1040 https://doi.org/10.1161/01.HYP.0000065618.56368.24
- Jeunemaitre X, Soubrier F, Kotelevtsev YV, Lifton RP, Williams, CS, Charru A, Hunt SC, Hopkins PN, Williams RR, Lalouel J-M and Corvol P. Molecular basis of human hypertension: role of angiotensinogen, Cell 1992; 71: 169-180 https://doi.org/10.1016/0092-8674(92)90275-H
- Kang BY, Kim KT, Shin JH, Om AS and Lee CC. The association between codon 192 polymorphism of paraox-onase/arylesterase gene and plasma HDL-cholesterol level in Korean population, Environ. Mutagens Carcinogens 2001; 21: 9-13
- La Du BN, Aviram M, Billecke S, Navab M, Primo-Parma S, Sorenson RC and Standiford TJ. On the physiological role(s) of the paraoxonase, Chemico-Biol. Interac. 1999; 119-120, 379-388 https://doi.org/10.1016/S0009-2797(99)00049-6
-
Leus FR, Zwart M, Kastelein JJ P and Voorbij HAM.
$PON_2$ gene variants are associated with clinical manifestations of cardiovascular disease in familial hypercholesterolemia patients, Atherosclerosis 2001; 154: 641-649 https://doi.org/10.1016/S0021-9150(00)00440-8 - Lifton RP, Gharavi AG and Geller DS. Molecular mecha-nisms of human hypertension, Cell 2001; 104: 545-556 https://doi.org/10.1016/S0092-8674(01)00241-0
- Mackness MI, Arrol S, Abbott CA and Dumngton PN. Is paraoxonase related to atherosclerosis? Chemico-Biol. Interac. 1993; 87: 161-171 https://doi.org/10.1016/0009-2797(93)90038-Z
- Mackness MI, Mackness B and Durrington PN. Paraoxonase and coronary heart disease, Atherosclerosis 2002; Suppl 3: 49-55 https://doi.org/10.1016/S1567-5688(02)00046-6
- Malin R, Rantalaiho V, Huang X-H, Wirta O, Pasternack A, Leinonen JS, Alho H, Jokela H, Koivula T, Tanaka T, Okada K, Ochi H, Toyokuni S and Lehtimaki T. Associ-ation between M/L55-polymorphism of paraoxonase enzyme and oxidative DNA damage in patients with type 2 diabetes mellitus and in control subjects, Hum. Genet. 1999: 105: 179-180
- Motti C, Dessi M, Gnasso A, Irace C, Indigene P, Angelucci CB, Bemardini S, Fucci G, Federici G and Cortese CA multiplex PCR-based DNA assay for the detection of paraoxonase gene cluster polymorphisms, Atherosclerosis 2001; 158: 35-40 https://doi.org/10.1016/S0021-9150(00)00765-6
- Primo-Parma SL, Sorenson RC, Teiber J and La Du BN. The human serum paraoxonase/arylesterase gene (PON1) is one member of a multigene family, Genomics 1996; 33: 498-509 https://doi.org/10.1006/geno.1996.0225
- Sambrook J, Fritsch EF and Maniatis T. Molecular Cloning -A Laboratory Manual. 2nd ed. Cold Spring Harbor NY, pp. 9.16-9.23
- Sanghera DK, Aston CE, Saha N and K.amboh MI. DNA polymorphisms in two paraoxonase genes (PON1 and PON2) are associated with the risk of coronary heart disease, Am. J. Hum. Genet. 1988; 62: 36-44 https://doi.org/10.1086/301669
- Serrato M and Marian AJ. A variant of human paraoxonase/arylesterase (HUMPONA) gene is a risk factor for coro-nary arteru disease, J. Clin. Invest. 1995; 96: 3005-3008 https://doi.org/10.1172/JCI118373
- Shi J, Zhang S, Tang M, Liu X, Li X, Li T, Han H, Wang Y, Guo Y, Zhao J, Li Hai and Ma C. Possible association between Cys311Ser polymorphism of paraoxonase 2 gene and late-onset Alzheimer's disease in Chinese, Mol. Brain Res. 2004; 120: 201-204 https://doi.org/10.1016/j.molbrainres.2003.10.018
-
Siffert W, Rosskop D, Siffert G, Busch S, Moritz A, Erbel R, Sharma AM, Ritz E, Wichmann H-E, Jakobs KH and Horsthemke B. Association of a human G-protein
$beta$ 3 subunit variant with hypertension, Nat. Genet. 1998; 18: 45-48 https://doi.org/10.1038/ng0198-45